Скачать с ютуб Life Science Venture Capital Perspectives в хорошем качестве

Life Science Venture Capital Perspectives

Recorded Live at the White Hat Life Science Investor Conference on September 19, 2024 at the Phoenix Convention Center. Moderated by Mara G. Aspinall, Partner, Illumina Ventures Mara Aspinall is a healthcare industry pioneer with a commitment to civic involvement and deep experience in leading genetics, genomics and diagnostics companies. Prior to joining Illumina Ventures, she co-founded BlueStone Venture Partners with a strong portfolio of diagnostic, medical device and digital health companies in the US Southwest. She has served as President and CEO of Ventana Medical Systems, a billion-dollar division of The Roche Group, (now Roche Tissue Diagnostics), and as President of Genzyme Genetics and Genzyme Pharmaceuticals. Featured Speaker Nick Shipley, Founder, Cronus Consulting Nick Shipley, based in Washington, DC, is currently a Founder at Cronus Consulting. Nick brings experience from previous roles at BIO, Pharmaceutical Researchers and Manufacturers Association, The McManus Group and U.S. House of Representatives.